Unique Ingredient Identifier PQ6CK8PD0R is listed as a ingredient substance
| RN | 50-81-7 |
| EC | 200-066-2 |
| NCIT | C285 |
| RXCUI | 1151 |
| PUBCHEM | 54670067 |
| INN ID | 372 |
| MF | C6H8O6 |
| INCHI KEY | CIWBSHSKHKDKBQ-JLAZNSOCSA-N |
| SMILES | OC[C@H](O)[C@H]1OC(=O)C(O)=C1O |
UNII PQ6CK8PD0R ASCORBIC ACID is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AN,INFILTRATION | INJECTION | NA |
| CAUDAL BLOCK | INJECTION | NA |
| EPIDURAL | INJECTION | NA |
| IM - IV | INJECTION | 0.2 % |
| INHALATION | AEROSOL, METERED | 959.5 MG/INH |
| INHALATION | AEROSOL, SPRAY | 0.11 % |
| INHALATION | SOLUTION | 1.02 % |
| INTRAMUSCULAR | INJECTION | 1 % |
| INTRAVENOUS | INJECTION | 120 MG/ML |
| INTRAVENOUS | INJECTION | 62.5 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 0.2 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.088 % |
| INTRAVENOUS | SOLUTION, INJECTION | 0.2 % |
| IV(INFUSION) | INJECTION | 50.4 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION | NA |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 48 % |
| NERVE BLOCK | INJECTION | NA |
| NERVE BLOCK | SOLUTION, INJECTION | 0.2 % |
| ORAL | CAPSULE | 7 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 0.4 MG |
| ORAL | CONCENTRATE | 6 MG/1ML |
| ORAL | POWDER, FOR ORAL SOLUTION | 5 MG |
| ORAL | SOLUTION | 30 MG/5ML |
| ORAL | SUSPENSION | 50 MG/5ML |
| ORAL | SUSPENSION, EXTENDED RELEASE | 2.93 MG/5ML |
| ORAL | SUSPENSION, SUSTAINED ACTION | NA |
| ORAL | SYRUP | 29.97 MG/5ML |
| ORAL | TABLET | 28.44 MG |
| ORAL | TABLET, FILM COATED | 20 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 2.35 MG |
| RECTAL | SUPPOSITORY | 3 MG |
| SUBCUTANEOUS | INJECTION | 1 % |
| TOPICAL | GEL | 0.3 %W/W |
| TOPICAL | SOLUTION | 0.044 %W/W |